GlassScriptPhysician profile
Mark Benedict Chen Cua
NPI 1841284668
$1,480.09
in general payments reported to CMS, 2019-2025
16 companies · $94.10 in 2025
The $94.10 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $63.23 · 2021: $270 · 2022: $209 · 2023: $202 · 2024: $91.03 · 2025: $94.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $290.92 | 2022-2023 | Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $215.37 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $158.69 | 2019-2022 | |
| Amarin Pharma, INC. | $145.44 | 2019-2020 | |
| Pfizer INC. | $138.24 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $127.23 | 2019-2024 | |
| Astellas Pharma US INC | $99.99 | 2019 | |
| Merck Sharp & Dohme LLC | $83.08 | 2021-2025 | Verquvo |
| Biotronik INC. | $47.19 | 2024 | Rivacor 7 Dr-T, Acticor 7 Vr-T Dx |
| Sanofi-Aventis U.S. LLC | $37.05 | 2019 | |
| Ge Healthcare | $36.88 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.76 | 2022-2023 | Lifevest |
| Amgen INC. | $24.42 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.42 | 2025 | Gattex |
| Novo Nordisk INC | $16.96 | 2025 | Wegovy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Cua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.